Site icon OncologyTube

MAVERICC Phase II study results Annual Meeting GI 2016

David H. Ilson, MD of Memorial Sloan Kettering Cancer Center discusses the MAVERICC Phase II study results at ASCO GI 2016

Exit mobile version